USEFULNESS OF TRANEXAMIC ACID IN REDUCING BLOOD LOSS DURING CAESAREAN DELIVERY IN IBADAN

EFFECT OF INTRAVENOUS TRANEXAMIC ACID IN REDUCING BLOOD LOSS DURING CAESAREAN DELIVERY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201804002955302

Enrollment

Registered

2018-01-09

Start date

2015-11-11

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Pregnancy and Childbirth HAEMORRHAGE

Interventions

Normal Saline

Traxenamic acid

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pregnant women scheduled for primary elective or emergency caesarean delivery

Exclusion criteria

Exclusion criteria: 1. Severe medical and surgical complications involving the heart, liver or kidney, and blood disorder. 2. Allergy to tranexamic acid. 3. Known risk factors for postpartum haemorrhage such as previous caesarean delivery, multiple pregnancy, placenta praevia, morbidly adherent placenta, previous myomectomy, co-existing uterine fibroid in pregnancy. 4. History of thrombo-embolic disorder or risk factors for thromboembolic disorder such as Sickle Cell disease. 5. Refusal to consent.

Design outcomes

Primary

Measure	Time frame
Amount of blood loss during caesarean delivery	—

Secondary

Measure	Time frame
Need for additional uterotonics;Need for other surgical measures to stop bleeding ;Maternal and neonatal side effects of medications given	—

Countries

Nigeria

Contacts

Public ContactTimothy Abiola O. Oluwasola

Consultant Obstetrician/Univerrsity College Hospital, Ibadan

sesanoluwasola@yahoo.com+2348033384064

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026